Edelife is a clinical study on the safety and possible health benefits of an investigational medicine for those affected by XLHED.
When given to XLHED-affected boys at the right time in the mother’s pregnancy, the investigational medicine should act as a replacement for a missing protein and potentially lead to improved development of a baby’s sweat glands, teeth, and skin.
If you are interested in taking part in the study or you have questions, please contact a Study Doctor.